Qindan-capsule inhibits proliferation of adventitial fibroblasts and collagen synthesis

被引:23
作者
Ren, Min [1 ]
Zhang, Jidong [1 ]
Wang, Bo [1 ]
Liu, Ping [2 ]
Jiang, Hong [3 ]
Liu, Guilin [4 ]
Yin, Huiqiu [5 ]
机构
[1] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Dept Hlth Management, Affiliated Hosp 2, Jinan 250033, Shandong, Peoples R China
[3] Shandong Univ, Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Shandong, Peoples R China
[4] Hosp Affiliated Shandong Acad Med Sci, Dept Med, Jinan 250062, Shandong, Peoples R China
[5] Bejing Novartis Pharma Co Ltd, CD&MA, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Adventitial fibroblast; TGF-beta/Smad; Extracellular matrix; Proliferation; IN-VIVO; SMAD; INJURY; TANG;
D O I
10.1016/j.jep.2010.03.004
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Aims: Qindan-capsule (QC) is a prescription of traditional Chinese medicine for the treatment of hypertension. We investigated the effect and mechanism of QC-containing serum on proliferation of aortal adventitial fibroblasts (AFs) and composition of extracellular matrix (ECM). We also tested whether the Smad3 signaling pathway is activated in the progress. Materials and methods: AFs were cultured by tissue explant in vitro. The proliferation of AFs induced by transforming growth factor beta 1 (TGF-beta 1) and affected by QC-containing serum with high or low dose was detected by MTT. The protein and mRNA expressions of Smad3 and Procollagen I were observed by Western blot and Real-time PCR respectively. Results: Western blot and Real-time PCR revealed that after being activated by TGF-beta 1 for 24 h, the expressions of Smad3, Pho-Smad3 and Procollagen I were all higher than those in the control group. But these functions were inhibited, to some extent in different doses, by QC-containing serum. So that the proliferation of AFs which was evaluated by MTT. Conclusions: The results suggested QC-containing serum has significantly improved proliferation of AFs and composition of extracellular matrix. TGF-beta 1/Smad3 signaling pathway may be involved in the mechanism. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 34 条
[1]
Salvia miltiorrhiza protects endothelial cells against oxidative stress [J].
Ding, M ;
Zhao, GR ;
Ye, TX ;
Yuan, YJ ;
Guo, ZX .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (01) :5-6
[2]
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies [J].
Dzau, VJ ;
Braun-Dullaeus, RC ;
Sedding, DG .
NATURE MEDICINE, 2002, 8 (11) :1249-1256
[3]
Smad3 as a mediator of the fibrotic response [J].
Flanders, KC .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2004, 85 (02) :47-64
[4]
Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II [J].
Galindo, M ;
Santiago, B ;
Palao, G ;
Gutierrez-Cañas, I ;
Ramirez, JC ;
Pablos, JL .
PEPTIDES, 2005, 26 (09) :1647-1653
[5]
Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomycin-exposed rats [J].
Gonzalez, Anne V. ;
Le Bellego, Frederique ;
Ludwig, Mara S. .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2007, 36 (02) :206-212
[6]
Guo SG, 2004, WORLD J GASTROENTERO, V10, P1487
[7]
Adventitia-dependent influences on vascular function [J].
Gutterman, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (04) :H1265-H1272
[8]
Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro [J].
Hao, JM ;
Wang, BQ ;
Jones, SC ;
Jassal, DS ;
Dixon, IMC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (06) :H3020-H3030
[9]
Intracellular TGF-β receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo [J].
Ishida, Wataru ;
Mori, Yasuji ;
Lakos, Gabriella ;
Sun, Lihong ;
Shan, Feng ;
Bowes, Scott ;
Josiah, Serene ;
Lee, Wen-Cherng ;
Singh, Juswinder ;
Ling, Leona E. ;
Varga, John .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (08) :1733-1744
[10]
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression [J].
Jinnin, M ;
Ihn, H ;
Tamaki, K .
MOLECULAR PHARMACOLOGY, 2006, 69 (02) :597-607